Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab + lenvatinib por previously untreated advanced or metastatic nccRCC
Phase: 2Phase II in Spain, 1Phase I